Paratus Clinical Research

Paratus Clinical Research is a premier clinical trial site network based in Australia, specializing in the execution of Phase 1 through Phase 4 clinical studies for the global pharmaceutical and biotechnology industries. Established in 2015, the company operates a network of dedicated research centers that provide comprehensive recruitment, regulatory, and study management services. In July 2022, Paratus was acquired by Velocity Clinical Research, a major US-based site organization, to serve as its foundational footprint in the Asia-Pacific region. The company is particularly recognized for its expertise in vaccine trials and infectious disease research, supported by a robust infrastructure and experienced medical investigators. By leveraging a centralized management model, Paratus ensures efficient study start-up and high patient retention rates across its multiple Australian locations.